MICALE, Vincenzo, Di Bartolomeo MARTINA, Di Martino SERENA, Tibor ŠTARK, Bernardo DELL'OSSO, Filippo DRAGO a Claudio ADDARIO. Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets. PHARMACOLOGY & THERAPEUTICS. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD, 2023, roč. 241, January 2023, s. 1-39. ISSN 0163-7258. Dostupné z: https://dx.doi.org/10.1016/j.pharmthera.2022.108279.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets
Autoři MICALE, Vincenzo (garant), Di Bartolomeo MARTINA, Di Martino SERENA, Tibor ŠTARK (703 Slovensko, domácí), Bernardo DELL'OSSO, Filippo DRAGO a Claudio ADDARIO.
Vydání PHARMACOLOGY & THERAPEUTICS, OXFORD, PERGAMON-ELSEVIER SCIENCE LTD, 2023, 0163-7258.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30104 Pharmacology and pharmacy
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 13.500 v roce 2022
Kód RIV RIV/00216224:14110/23:00130255
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.pharmthera.2022.108279
UT WoS 000906912700004
Klíčová slova anglicky Schizophrenia; Bipolar disorder; Depression; DNA methylation; Epigenetics; Antidepressants; Antipsychotics
Štítky 14110516, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 31. 1. 2023 10:39.
Anotace
The etiopathogenesis of mental disorders is not fully understood and accumulating evidence support that clinical symptomatology cannot be assigned to a single gene mutation, but it involves several genetic factors. More specifically, a tight association between genes and environmental risk factors, which could be mediated by epigenetic mechanisms, may play a role in the development of mental disorders. Several data suggest that epigenetic modifications such as DNA methylation, post-translational histone modification and interference of microRNA (miRNA) or long non-coding RNA (lncRNA) may modify the severity of the disease and the outcome of the therapy. Indeed, the study of these mechanisms may help to identify patients particularly vulnerable to mental disorders and may have potential utility as biomarkers to facilitate diagnosis and treatment of psychiatric disorders. This article summarizes the most relevant preclinical and human data showing how epigenetic modifications can be central to the therapeutic efficacy of antidepressant and/or antipsychotic agents, as possible predictor of drugs response.
VytisknoutZobrazeno: 9. 7. 2024 11:40